Drug Delivery

Novocol Healthcare Partners with Duoject to Expand Injectable Capabilities

Novocol Healthcare, Inc. (NHI), a subsidiary of Septodont, Inc. and a manufacturer of sterile injectables, announced the acquisition of a majority stake in Duoject Medical Systems, Inc. (Duoject), a medical device supplier.

According to Novocol, the partnership between the companies will bring additional value to its development projects, and will allow NHI to offer more injection devices and reconstitution systems to its pharmaceutical filling customers.

Bespak Launches Syrina 2.25 Auto Injector at PDA Europe

Bespak, a global drug delivery company, launched its Syrina 2.25 auto injector at PDA Europe 2015 in Vienna. The company's global business development lead, Steven Kaufman, also chaired a one-day specialized industry discussion on innovative combinational products at a workshop Nov. 3-4 at the event's renowned Universe of Pre-filled Syringes & Injection Devices in Vienna.

Raumedic to Show Award-Winning RauSafe at MD&M Minneapolis

Polymer specialist Raumedic will be presenting the latest developments in its pharmaceutical packaging and drug delivery at the Minnesota Medtech Week, the healthtech industry event of this autumn. Namely, the company will be showing off its RauSafe safety device for injection systems, the XStraw drug delivery system, and its latest dosage syringe with an external locking mechanism for the application of liquid drugs.

2015 CPhI Annual Report to be Focus of Oct. 14 Twitter Chat

The release of the third part of the 2015 CPhI Worldwide annual report was announced in Madrid on Tuesday. It is titled “Push-pull factors on growth” and contains a look at the implications at the implications of United States trade law regulations on generics access, the growth of steriles manufacturing and outsourcing, and the positive impact QbD, “technology commons,” and “outsourced regulators” could being to bear in improving manufacturing standards.

3M Drug Delivery Systems and Impel NeuroPharma Form Alliance

3M Drug Delivery Systems (3M) announced signing a strategic agreement with Impel NeuroPharma Inc. to accelerate commercialization and cost effectiveness of its Precision Olfactory Delivery (POD) technology platform and Impel’s growing portfolio of enhanced Central Nervous System products.

Phillips-Medisize Invited to Join Sanofi at Partnerships in Drug-Delivery

Phillips-Medisize Corp. representatives Bill Welch, chief technology officer, and Janne Turunen, program manager, will be part of the Sanofi presentation at the Partnership Opportunities in Drug Delivery (PODD) in Boston on Oct. 5.

The PODD conference brings together leaders in the pharma/biotech industry for networking and presentations on the latest drug delivery technologies, as well as insights on delivery and formulation needs. The ultimate goal of the conference is to inspire innovation and advancement of drug development and delivery.

WestRock Launches the HiMark Child-Resistant Nasal Pump

WestRock Company announced the launch of the HiMark CR Nasal Pump, which is now in use for nasal medications in retail pharmacies across the United States.

According to the company, the new packaging design was developed using patient insights and will facilitate a better medication usage experience. The new packaging integrates safety features that are both child-resistant and patient-centric.

What Will Drive Disruption?

In last issue’s Industry Outlook feature, we examined the potential for disruption in pharmaceutical packaging. With more patients thanks to the Affordable Care Act, more cost sensitivities throughout the system, and an increasing population of chronically ill patients, will healthcare payers look for products and packaging that improve the quality of care cost efficiently? Could this drive disruption? 

St-Hubert Restaurants to Stock Allerject Epinephrine Auto-Injectors

The St-Hubert restaurant chain is teaming up with Sanofi Canada to stock Allerject epinephrine auto-injectors in all of its 117 locations in Quebec, Ontario, and New Brunswick, the company announced.

Lilly's Humalog 200 Units/mL KwikPen Now Available in U.S. Pharmacies

Humalog 200 units/mL KwikPen (insulin lispro 200 units/mL; U-200), a concentrated mealtime insulin analog, is now available in pharmacies, Eli Lilly and Company announced. 

Humalog U-200 KwikPen is a prefilled pen containing a concentrated formulation of Lilly's rapid-acting insulin Humalog (insulin lispro 100 units/mL) to improve glycemic control in people with type 1 and type 2 diabetes. It is intended for people who are already taking mealtime insulin.

Syndicate content